Cambridge Cognition Holdings PLC Contract Win (1347L)
29 September 2016 - 4:00PM
UK Regulatory
TIDMCOG
RNS Number : 1347L
Cambridge Cognition Holdings PLC
29 September 2016
29 September 2016
Cambridge Cognition Holdings Plc
('Cambridge Cognition' or the 'Company')
Major contract wins for CANTAB Connect
The neuroscience company Cambridge Cognition Holdings PLC
(Cambridge, UK - LSE: COG), which develops and markets near patient
technologies to facilitate early intervention and development of
treatments for neurological disorders, today announces the signing
of two major contracts using the Company's CANTAB Connect
technology.
The contracts totalling US$3.67million (GBP2.82 million) are
with US biopharmaceutical companies for late stage clinical trials
and will contribute US$1.07 million (GBP0.82 million) to reported
revenue in the second half of 2016.
The award of the contracts was expected and so the outlook for
the current year remains unchanged.
Steven Powell, PhD, Chief Executive Officer, Cambridge
Cognition: "Securing these contracts is further evidence of the
concerted effort being made to accelerate revenue growth from our
core businesses in Academic Research and Pharmaceutical Clinical
Trials. Not only do we expect to secure further business from core
CANTAB Connect products such as those used in the above contracts,
but also products such as CANTAB Recruit and Cognition Kit which we
introduced into our product portfolio earlier this year."
Notes to editors
About Cambridge Cognition
Cambridge Cognition is an international neuroscience company
which develops and markets near patient cognitive assessment
products to improve the understanding, diagnosis and treatment of
neurological and psychiatric disorders.
For over 30 years the company's patented technology has advanced
the assessment of cognition to accelerate the development of safe
and effective treatments, improve patient outcomes and measure
cognitive health throughout life.
Partners include the world's leading biotechnology and
pharmaceutical companies, academic institutions and public-private
healthcare providers.
www.cambridgecognition.com
Enquiries
Cambridge Cognition Holdings PLC
Steven Powell, Chief Executive Tel: 01223 810
Officer 700
Noah Konig, Director of Product press@camcog.com
Marketing and Communications
finnCap Ltd (NOMAD and Joint Broker) Tel: 020 7220
0500
Geoff Nash / Simon Hicks (Corporate Finance)
Alice Lane (Corporate Broking)
Hybridan LLP (Joint Broker) Tel: 020 3764
2341
Claire Noyce (Corporate Broking)
This information is provided by RNS
The company news service from the London Stock Exchange
END
CNTUWANRNVAKUAR
(END) Dow Jones Newswires
September 29, 2016 02:00 ET (06:00 GMT)
Cambridge Cognition (LSE:COG)
Historical Stock Chart
From Apr 2024 to May 2024
Cambridge Cognition (LSE:COG)
Historical Stock Chart
From May 2023 to May 2024